Both compounds were tested against a panel of human bladder cancer cell lines (TSU-Pr1, TSU-Pr1-B1, and TSU-Pr1-B2) and the superficial bladder cancer cell line 5637. Here, TMEM37 is linked to urinary bladder cancer.